Healthcare Marketing and Consumer Engagement – Patient Education, Shared Decision-Making

Definition and Core Concept

This article defines Healthcare Marketing as strategies and activities used to communicate health information, promote services, and engage individuals in their own care. Unlike commercial marketing, healthcare marketing emphasises education, behaviour change, and patient empowerment. Consumer engagement refers to efforts that enable individuals to become active participants in health decisions, using tools such as patient portals, decision aid, and personalised communication. Core features: (1) patient education materials (plain language, visual aid, digital content), (2) shared decision-making (SDM) (structured conversations about options, risks, preferences), (3) digital engagement (portals, text reminders, apps), (4) community outreach (events, partnerships, social media), (5) branding and reputation management for healthcare organisations. The article addresses: objectives of healthcare marketing; key concepts including health literacy, decision aid, and patient activation; core mechanisms such as A/B testing of messages, segmentation, and multi-channel campaigns; international comparisons and debated issues (ethical boundaries, privacy, effectiveness measurement); summary and emerging trends (personalised messaging, AI chatbots, video decision aid); and a Q&A section.

1. Specific Aims of This Article

This article describes healthcare marketing and consumer engagement without endorsing specific products. Objectives commonly cited: increasing preventive service uptake, improving medication adherence, reducing no-show rates, enhancing patient satisfaction, and supporting informed choices.

2. Foundational Conceptual Explanations

Key terminology:

• Shared decision-making (SDM): Collaborative process where clinician and patient discuss evidence-based options, patient values, and preferences, then jointly decide on a plan.
• Patient decision aid: Tool (paper, video, interactive) presenting options, benefits, harms, and probabilities to support SDM.
• Patient activation measure (PAM): Scale assessing knowledge, skills, and confidence for self-management. Higher activation predicts better outcomes and lower costs.

Marketing channels in healthcare:

• Traditional: mailers, print, radio, events, referrals.
• Digital: websites, portals, email, SMS, social media, search ads, patient portals.

3. Core Mechanisms and In-Depth Elaboration

Ethical principles for healthcare marketing:

• Accuracy (no misleading claims).
• Privacy (no sharing of patient data without consent).
• Respect (avoid fear-based messaging, stigma).
• Transparency (sponsored content, conflicts of interest).

Shared decision-making implementation:

• Three-talk model (Team talk, Option talk, Decision talk).
• Evidence: SDM improves patient knowledge (d=0.6), reduces decisional conflict (d=0.4), and may reduce overuse of preference-sensitive procedures (e.g., joint replacement, back surgery) by 10-20%.

Digital engagement effectiveness:

• Text message reminders reduce no-show rates (by 20-30%).
• Patient portal use associated with higher preventive care uptake (10-15% increase).
• Personalisation (name, relevant health data) improves response rates (2-5x).

4. International Comparisons and Debated Issues

Regulatory context:

Debated issues:

1. Direct-to-consumer (DTC) advertising (US, NZ only): Increases awareness but also drives overuse and higher costs. Evidence on health benefits is weak.
2. Use of patient data for targeting: Privacy concerns; balancing personalised outreach with consent is essential.
3. Return on investment (ROI) measurement: Attribution is difficult; many campaigns use proxy metrics (clicks, calls, visits) rather than health outcomes.

5. Summary and Future Trajectories

Summary: Healthcare marketing emphasises patient education and engagement, not promotion. Shared decision-making and decision aid improve knowledge and reduce overuse. Digital tools (portals, text reminders) modestly improve adherence and attendance. Ethical oversight is critical.

Emerging trends:

• AI-powered chatbots for patient inquiries, appointment scheduling, medication refills.
• Personalised video decision aid tailored to patient demographics, health literacy.
• Social media for health promotion (chronic disease communities, public health campaigns).

6. Question-and-Answer Session

Q1: Is healthcare marketing allowed to use patient testimonials?
A: Yes, but must be truthful, not misleading, and comply with privacy regulations (patient authorisation required). Testimonials cannot claim superior outcomes unless evidence supports.

Q2: Can a hospital send appointment reminders without patient permission?
A: Yes, as treatment-related communication, not marketing. Reminders (phone, email, text) are generally exempt from opt-in requirements.

Q3: Does shared decision-making increase consultation time?
A: Initially yes, by 2-5 minutes per visit for relevant decisions. After training, clinicians integrate SDM efficiently. Benefits (satisfaction, adherence, reduced overuse) outweigh time cost.
https://www.england.nhs.uk/shared-decision-making/
https://www.ahrq.gov/patient-engagement/index.html